We are live on
!
Find out more
SCM
Scopia Capital Management Portfolio holdings
AUM
$112M
Turnover
21.74%
1-Year Est. Return
48.41%
This Fund
S&P 500
This Quarter
Est. Return
+8.06%
1 Year Est. Return
+48.41%
3 Year Est. Return
+58.7%
5 Year Est. Return
+80.15%
10 Year Est. Return
+533.22%
AUM
$819M
AUM Growth
+$126M
(+18%)
Cap. Flow
+$81.6M
Cap. Flow
% of AUM
9.96%
Top 10 Holdings %
Top 10 Hldgs %
58.25%
Holding
35
New
13
Increased
10
Reduced
8
Closed
3
Avg Time Held
1.2
years
Top 10 Avg Time Held
0.7
years
Top 20 Avg Time Held
1.3
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
LivaNova
LIVN
|
+$33.6M |
| 2 |
UnitedHealth
UNH
|
+$29.9M |
| 3 |
TSMC
TSM
|
+$22.5M |
| 4 |
Bio-Rad Laboratories Class A
BIO
|
+$22.4M |
| 5 |
Chemours
CC
|
+$15.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
DraftKings
DKNG
|
+$31M |
| 2 |
Valvoline
VVV
|
+$22.5M |
| 3 |
Mercury Systems
MRCY
|
+$20.7M |
| 4 |
Dollar Tree
DLTR
|
+$20.6M |
| 5 |
AerCap
AER
|
+$11.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 31.54% |
| 2 | Consumer Discretionary | 25.34% |
| 3 | Healthcare | 14.17% |
| 4 | Materials | 12.43% |
| 5 | Technology | 9.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
26
Atlanta Braves Holdings Series B
BATRK
$3.17B
| $8.76M | 1.07% |
+187,194
| New | +$7.65M |
2025 Q2
0 quarters
|
|
27
Humana
HUM
$51.9B
| $5.09M | 0.62% |
20,830
| – | – |
2024 Q1
5 quarters
|
|
28
Carvana
CVNA
$66.7B
| $2.62M | 0.32% |
+38,860
| New | +$2.13M |
2025 Q2
0 quarters
|
|
29
MannKind Corp
MNKD
$1.03B
| $2.6M | 0.32% |
+694,961
| New | +$3.06M |
2025 Q2
0 quarters
|
|
30
Mobileye
MBLY
$6.32B
| $1.44M | 0.18% |
+79,899
| New | +$1.22M |
2025 Q2
0 quarters
|
|
31
DELISTED
TPI Composites
TPIC
| $56.8K | 0.01% |
+66,074
| New | +$67.2K |
2025 Q2
0 quarters
|
|
32
DELISTED
Leslie's
LESL
| $41K | 0.01% |
+4,885
| New | +$64.3K |
2025 Q2
0 quarters
|
|
|
33
DraftKings
DKNG
$9.59B
| – | – |
-877,976
| Closed | -$31M | – |
|
|
34
Dollar Tree
DLTR
$23.3B
| – | – |
-283,651
| Closed | -$20.6M | – |
|
35
Cedar Fair
FUN
$875M
| – | – |
-314,962
| Closed | -$11.2M | – |
|
Similar funds
TFS
WAM
CS
BU
TBFA
VDC
RQS
IMT
Scopia Capital Management's Q2 2025 Portfolio in Review
As of Q2 2025, Scopia Capital Management held 35 positions worth $819M, up 18% from $692M the previous quarter. Its ten largest holdings account for 58% of the portfolio.
Scopia Capital Management deployed $81.6M of net new capital in Q2 2025, opening 13 new positions and adding to 10 existing holdings. Its largest new stake was LivaNova: 814,243 shares worth $36.7M.
By sector, the portfolio is most concentrated in Industrials at 32% of assets, down from 37% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was Valvoline, an estimated $22.5M trimmed.
- Scopia Capital Management's largest Q2 2025 buy was LivaNova: 814,243 shares worth $36.7M.
- Scopia Capital Management added most to Chemours in Q2 2025, an estimated $15.8M increase.
- Scopia Capital Management's biggest Q2 2025 reduction was Valvoline, cutting an estimated $22.5M.
- Scopia Capital Management fully exited DraftKings in Q2 2025, selling an estimated $31M.
- Scopia Capital Management's ten largest holdings make up 58% of its $819M portfolio in Q2 2025.
- Scopia Capital Management opened 13 new positions and closed 3 in Q2 2025.
- Scopia Capital Management's portfolio value rose 18% quarter-over-quarter to $819M.
Based on Scopia Capital Management's 13F filing for Q2 2025, filed 14 Aug 2025.